57 related articles for article (PubMed ID: 29032268)
1. Total Marrow Lymphoid Irradiation/Fludarabine/ Melphalan Conditioning for Allogeneic Hematopoietic Cell Transplantation.
Jensen LG; Stiller T; Wong JYC; Palmer J; Stein A; Rosenthal J
Biol Blood Marrow Transplant; 2018 Feb; 24(2):301-307. PubMed ID: 29032268
[TBL] [Abstract][Full Text] [Related]
2. Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience review.
Wong JYC; Liu A; Han C; Dandapani S; Schultheiss T; Palmer J; Yang D; Somlo G; Salhotra A; Hui S; Al Malki MM; Rosenthal J; Stein A
Front Oncol; 2022; 12():1003908. PubMed ID: 36263219
[TBL] [Abstract][Full Text] [Related]
3. Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation.
Kuriyama K; Fuji S; Ito A; Doki N; Katayama Y; Ohigashi H; Nishida T; Serizawa K; Eto T; Uchida N; Kanda Y; Tanaka M; Matsuoka KI; Nakazawa H; Kanda J; Fukuda T; Atsuta Y; Ogata M
Transplant Cell Ther; 2024 May; 30(5):514.e1-514.e13. PubMed ID: 38373522
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11.
Sakashita K; Yoshida N; Muramatsu H; Ohtsuka Y; Watanabe K; Yabe M; Kakuda H; Honda Y; Watanabe T; Haba M; Ohmori S; Matsuda K; Yuza Y; Saito A; Horibe K; Adachi S; Manabe A
Transplant Cell Ther; 2024 Jan; 30(1):105.e1-105.e10. PubMed ID: 37806448
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
Chichra A; Nayak L; Kothari R; Kalantri S; Bonda A; Gokarn A; Punatar S; Mirgh S; Jindal N; Bagal B; Kannan S; Mathew L; Khattry N
Int J Hematol; 2024 Jan; 119(1):71-79. PubMed ID: 37952243
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.
Saad A; Mahindra A; Zhang MJ; Zhong X; Costa LJ; Dispenzieri A; Drobyski WR; Freytes CO; Gale RP; Gasparetto CJ; Holmberg LA; Kamble RT; Krishnan AY; Kyle RA; Marks D; Nishihori T; Pasquini MC; Ramanathan M; Lonial S; Savani BN; Saber W; Sharma M; Sorror ML; Wirk BM; Hari PN
Biol Blood Marrow Transplant; 2014 Mar; 20(3):402-408.e1. PubMed ID: 24342394
[TBL] [Abstract][Full Text] [Related]
7. Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Hui S; Brunstein C; Takahashi Y; DeFor T; Holtan SG; Bachanova V; Wilke C; Zuro D; Ustun C; Weisdorf D; Dusenbery K; Verneris MR
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1110-1116. PubMed ID: 28396164
[TBL] [Abstract][Full Text] [Related]
8. Phase 1 Study of Bortezomib, Fludarabine, and Melphalan, With or Without Total Marrow Irradiation, as Allogeneic Hematopoietic Stem Cell Transplant Conditioning for High-risk or Relapsed/Refractory Multiple Myeloma.
Ladbury C; Sanchez J; Chowdhury A; Palmer J; Liu A; Stein A; Htut M; Farol L; Cai JL; Somlo G; Rosenzweig M; Wong JC; Sahebi F
Am J Clin Oncol; 2024 Mar; ():. PubMed ID: 38483213
[TBL] [Abstract][Full Text] [Related]
9. Considerations for intensity modulated total body or total marrow and lymphoid irradiation.
Parsons D; Lim TY; Teruel JR; Galavis P; Agostinelli S; Liang J; Mancosu P; Cherpak A; Stanley DN; Ahn KH; Guo B; Gonzalez Y; Burmeister J; Wong JYC; Gu X; Kim GG
Clin Transl Radiat Oncol; 2023 Nov; 43():100674. PubMed ID: 37753462
[TBL] [Abstract][Full Text] [Related]
10. Editorial: Total marrow irradiation.
Hui SK; Storme G; Wong J; Aristei C; Al Malki MM; Aydogan B
Front Oncol; 2023; 13():1240530. PubMed ID: 37538119
[No Abstract] [Full Text] [Related]
11. Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma.
Epperla N; Ahn KW; Armand P; Jaglowski S; Ahmed S; Kenkre VP; Savani B; Jagasia M; Shah NN; Fenske TS; Sureda A; Smith SM; Hamadani M
Biol Blood Marrow Transplant; 2018 Jan; 24(1):78-85. PubMed ID: 29032272
[TBL] [Abstract][Full Text] [Related]
12. Influence of a dosing-time on toxicities induced by docetaxel, cisplatin and 5-fluorouracil in patients with oral squamous cell carcinoma; a cross-over pilot study.
Tsuchiya Y; Ushijima K; Noguchi T; Okada N; Hayasaka JI; Jinbu Y; Ando H; Mori Y; Kusama M; Fujimura A
Chronobiol Int; 2018 Feb; 35(2):289-294. PubMed ID: 29144178
[TBL] [Abstract][Full Text] [Related]
13. Total marrow and lymphoid irradiation with helical tomotherapy: a practical implementation report.
Chilukuri S; Sundar S; Thiyagarajan R; Easow J; Sawant M; Krishanan G; Panda PK; Sharma D; Jalali R
Radiat Oncol J; 2020 Sep; 38(3):207-216. PubMed ID: 33012149
[TBL] [Abstract][Full Text] [Related]
14. Comparing the outcomes between TMLI and non-TMLI conditioning regimens for adult high-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a single-center experience.
Zhao X; Lu X; Tang L; Yan H; Chen W; Shi W; Zhong Z; You Y; Xia L; Hu Y; Wang H
Leuk Lymphoma; 2020 Dec; 61(12):2859-2867. PubMed ID: 32654551
[TBL] [Abstract][Full Text] [Related]
15. Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review.
Paix A; Antoni D; Waissi W; Ledoux MP; Bilger K; Fornecker L; Noel G
Crit Rev Oncol Hematol; 2018 Mar; 123():138-148. PubMed ID: 29482775
[TBL] [Abstract][Full Text] [Related]
16. Maintain Efficacy and Spare Toxicity: Traditional and New Radiation-Based Conditioning Regimens in Hematopoietic Stem Cell Transplantation.
Dogliotti I; Levis M; Martin A; Bartoncini S; Felicetti F; Cavallin C; Maffini E; Cerrano M; Bruno B; Ricardi U; Giaccone L
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473227
[TBL] [Abstract][Full Text] [Related]
17. Total marrow lymphoid irradiation IMRT treatment using a novel CT-linac.
Jiang D; Deng D; Xiong Y; Wang D; Gong J; Zhao H; Bao Z; Wei Y; Xie C; Jia L; Liao C; Liu S; Liu H; Wang X
Eur J Med Res; 2023 Oct; 28(1):463. PubMed ID: 37884978
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of total marrow lymphoid irradiation with volumetric modulated arc therapy: clinical implementation in a tertiary care center.
Godson HF; Raj JS; Sebastian P; Ponmalar RY; Babu ES; Paul I; Krishna R; Backianathan S; George B; Ravindran PB; Balakrishnan R
Strahlenther Onkol; 2023 Oct; 199(10):922-935. PubMed ID: 37278833
[TBL] [Abstract][Full Text] [Related]
19. Total marrow irradiation in hematopoietic stem cell transplantation for hematologic malignancies.
Kerbauy MN; Arcuri LJ; Favareto SL; de Rezende ACP; Hamerschlak N
Front Med (Lausanne); 2023; 10():1155954. PubMed ID: 37153098
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
